Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07046767 · ClinicalTrials.gov registry record · NA

CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations

A NA study of Venous Leg Ulcer and Diabetic Foot Ulcer (DFU), sponsored by Capsicure.

Recruiting
Registry status
NA
Development phase
165
Enrollment target
7
Study locations

NCT07046767: Recruiting NA study of Venous Leg Ulcer and Diabetic Foot Ulcer (DFU), sponsored by Capsicure.

NCT07046767 is a NA study of Venous Leg Ulcer and Diabetic Foot Ulcer (DFU) that is actively recruiting participants, run by Capsicure. The registered enrollment target is 165 participants, below the 240-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (31% lower). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07046767, a NA study of Venous Leg Ulcer and Diabetic Foot Ulcer (DFU), is actively recruiting participants, sponsored by Capsicure.

RECRUITING
Registry status
NA
Development phase
165 participants
Enrollment target
7
Study locations

Study Summary

CAMP RWE Trial: A Multicenter hybrid platform trial comparing the effects of a prospective cohort treated with a tri-layer amnion graft or a single layer amnion graft to a coarsened exact matched retrospective control cohort of patients with hard-to-heal DFUs and VLUs

Primary Outcome

To demonstrate the clinical effectiveness of IP1 and IP2 as an adjunct to standard of care in supporting wound healing compared to standard of care alone in venous leg ulcers and diabetic foot ulcers across the continuum of care. Thus, the incidence of index ulcers obtaining complete wound closure by 12 weeks will be collected.

Interventions

  • OTHER IP1: BioLab Membrane Wrap Lite IP2: BioLab Tri-Membrane Wrap
  • OTHER IP2: BioLab Tri-Membrane Wrap

Study Locations (7)

Florida

  • Solutions Medical Research - Coral Gables
  • Nova Medical Services - Research Division LLC - Miami

California

  • FOMAT Medical Research - Oxnard

Indiana

  • Indiana University Health Methodist Hospital - Indianapolis

Missouri

  • St. Louis Foot and Ankle, LLC - St Louis

New York

  • Jevlos Health, Inc - Syosset

Texas

  • Hope Vascular and Podiatry - Houston

Trial Details

FieldValue
Enrollment Target 165 participants
Start Date 2025-10-01
Est. Completion 2026-07-20
Phase NA
Capsicure

3 total trials

What NCT07046767 shows while recruiting

NCT07046767 is an interventional study that assigns participants to a tested intervention. The registered 165 participants enrollment target is mid-sized for trials with a published cap, below the 240-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (31% lower).

The record links to 3 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which IP1: BioLab Membrane Wrap Lite IP2: BioLab Tri-Membrane Wrap is the first listed.

NCT07046767 lists 7 locations in 6 states (Florida, California, Indiana).

Frequently Asked Questions

What is clinical trial NCT07046767 about?

NCT07046767 is a clinical study titled "CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations". CAMP RWE Trial: A Multicenter hybrid platform trial comparing the effects of a prospective cohort treated with a tri-layer amnion graft or a single layer amnion graft to a coarsened exact matched retrospective control cohort of patients with hard-to-heal DFUs and VLUs

What is the current status of trial NCT07046767?

This trial is currently recruiting. It is a NA study. The enrollment target is 165 participants. The study started on 2025-10-01. Estimated completion is 2026-07-20.

What conditions does trial NCT07046767 study?

This clinical trial studies the following conditions: Venous Leg Ulcer, Diabetic Foot Ulcer (DFU), Wound; Foot.

What interventions are being tested in trial NCT07046767?

The interventions under investigation include: IP1: BioLab Membrane Wrap Lite IP2: BioLab Tri-Membrane Wrap (OTHER), IP2: BioLab Tri-Membrane Wrap (OTHER).

Who is sponsoring clinical trial NCT07046767?

This trial is sponsored by Capsicure, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07046767 being conducted?

This trial has 7 study locations across California, Florida, Indiana, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Leg Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07046767's enrollment target sits among peer trials

165 15th of 35 higher than 20 of 35 other Venous Leg Ulcer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Venous Leg Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02387255 · 165 participants

    Magnetic Resonance Elastography in Patients With Abdominal Aortic Aneurysms

  • NCT03351348 · 165 participants · Phase 3

    Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

  • NCT03830320 · 165 participants · Phase 1

    Positron Emission Tomography (PET) Imaging of Thrombosis

  • NCT04289571 · 165 participants · Phase 1

    Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07046767, the US trial registry maintained by the National Library of Medicine. NCT07046767 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.